A.R.PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
A.R.PHARMA
Largest movements
- Current investments +€119,413
up €119,413 (+51.8%), from €230,370 to €349,783
- Cash +€76,661
up €76,661 (+14.8%), from €517,760 to €594,422
mainly Net result for the year (+€157,946) and Receivables within one year (+€64,123)
- Receivables within one year -€64,123
down €64,123 (-11.4%), from €563,774 to €499,651
of which Other amounts receivable: -€56,788
- Tangible fixed assets -€31,997
down €31,997 (-19.8%), from €161,397 to €129,401
of which Land and buildings: -€18,196
- Intangible fixed assets -€22,713
down €22,713 (-6.7%), from €340,697 to €317,984
- Reserves +€157,946
up €157,946 (+12.1%), from €1.3m to €1.5m
- Current portion of long-term debt -€74,988
down €74,988 (-63.4%), from €118,208 to €43,220
- Other debts +€58,516
up €58,516 (+16.7%), from €349,639 to €408,155
- Debts after one year -€34,004
no longer reported in 2025 (was €34,004)
- Financial charges +€12,781
up €12,781 (+28.6%), from €44,687 to €57,468
- Gross operating margin -€8,670
down €8,670 (-2.1%), from €408,008 to €399,339
- Financial income +€8,119
up €8,119 (+180.5%), from €4,497 to €12,616
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,989,932 | €2,087,522 | +€97,590 | +4.9% |
| Fixed assets | 21/28 | €502,095 | €447,385 | -€54,710 | -10.9% |
| Intangible fixed assets | 21 | €340,697 | €317,984 | -€22,713 | -6.7% |
| Tangible fixed assets | 22/27 | €161,397 | €129,401 | -€31,997 | -19.8% |
| Land and buildings | 22 | €128,193 | €109,997 | -€18,196 | -14.2% |
| Plant, machinery and equipment | 23 | €2,124 | €1,285 | -€839 | -39.5% |
| Furniture and vehicles | 24 | €31,081 | €18,119 | -€12,962 | -41.7% |
| Current assets | 29/58 | €1,487,837 | €1,640,138 | +€152,300 | +10.2% |
| Stocks and contracts in progress | 3 | €173,638 | €193,927 | +€20,289 | +11.7% |
| Stocks | 30/36 | €173,638 | €193,927 | +€20,289 | +11.7% |
| Amounts receivable within one year | 40/41 | €563,774 | €499,651 | -€64,123 | -11.4% |
| Trade receivables | 40 | €150,448 | €143,113 | -€7,335 | -4.9% |
| Other amounts receivable | 41 | €413,326 | €356,538 | -€56,788 | -13.7% |
| Current investments | 50/53 | €230,370 | €349,783 | +€119,413 | +51.8% |
| Cash at bank and in hand | 54/58 | €517,760 | €594,422 | +€76,661 | +14.8% |
| Deferred charges and accrued income | 490/1 | €2,294 | €2,354 | +€60 | +2.6% |
| Total equity and liabilities | 10/49 | €1,989,932 | €2,087,522 | +€97,590 | +4.9% |
| Equity | 10/15 | €1,320,963 | €1,478,909 | +€157,946 | +12.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,308,563 | €1,466,509 | +€157,946 | +12.1% |
| Distributable reserves | 133 | €1,308,563 | €1,466,509 | +€157,946 | +12.1% |
| Amounts payable | 17/49 | €668,969 | €608,613 | -€60,355 | -9.0% |
| Amounts payable after more than one year | 17 | €34,004 | - | -€34,004 | |
| Financial debts | 170/4 | €34,004 | - | -€34,004 | |
| Amounts payable within one year | 42/48 | €619,553 | €594,088 | -€25,464 | -4.1% |
| Current portion of amounts payable after more than one year | 42 | €118,208 | €43,220 | -€74,988 | -63.4% |
| Trade debts | 44 | €102,878 | €98,225 | -€4,653 | -4.5% |
| Suppliers | 440/4 | - | €98,225 | +€98,225 | |
| Bills of exchange payable | 441 | €102,878 | - | -€102,878 | |
| Taxes, remuneration and social security | 45 | €48,828 | €44,489 | -€4,339 | -8.9% |
| Taxes | 450/3 | €37,657 | €32,320 | -€5,337 | -14.2% |
| Remuneration and social security | 454/9 | €11,171 | €12,169 | +€998 | +8.9% |
| Other amounts payable | 47/48 | €349,639 | €408,155 | +€58,516 | +16.7% |
| Accrued charges and deferred income | 492/3 | €15,413 | €14,525 | -€887 | -5.8% |
| Remuneration, social security and pensions | 62 | €65,949 | €63,948 | -€2,001 | -3.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €57,630 | €54,710 | -€2,920 | -5.1% |
| Other operating charges | 640/8 | €1,198 | €1,434 | +€236 | +19.7% |
| Gross operating margin | 9900 | €408,008 | €399,339 | -€8,670 | -2.1% |
| Operating profit (loss) | 9901 | €283,231 | €279,246 | -€3,985 | -1.4% |
| Financial income | 75/76B | €4,497 | €12,616 | +€8,119 | +180.5% |
| Recurring financial income | 75 | €4,497 | €12,616 | +€8,119 | +180.5% |
| Financial charges | 65/66B | €44,687 | €57,468 | +€12,781 | +28.6% |
| Recurring financial charges | 65 | €44,687 | €57,468 | +€12,781 | +28.6% |
| Profit (loss) for the period before taxes | 9903 | €243,041 | €234,394 | -€8,647 | -3.6% |
| Income taxes | 67/77 | €77,933 | €76,449 | -€1,484 | -1.9% |
| Profit (loss) for the period | 9904 | €165,108 | €157,946 | -€7,163 | -4.3% |
| Profit (loss) for the period to be appropriated | 9905 | €165,108 | €157,946 | -€7,163 | -4.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.